COVID-19 reinfection in a patient with a serious mental illness within a long-term inpatient psychiatric care hospital
There is an increasing number of case reports of COVID-19 reinfection. The mechanism of reinfection is poorly understood and evolving. Prevention of the transmission of severe acute respiratory syndrome coronavirus 2 for those with a serious mental illness (SMI) living in a congregate setting presen...
Saved in:
Main Authors: | Brianna Englett, PharmD, BCPP (Author), Amy Magdalany, PharmD (Author), Tiffany L. Gordon, PharmD, BCPP (Author), Kelly Holladay, PharmD, BCPP (Author) |
---|---|
Format: | Book |
Published: |
American Association of Psychiatric Pharmacists,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characterization of inpatient care for patients admitted to a psychiatric hospital with a home opioid prescription
by: Kei Takamura, PharmD, BCPS, BCPP, et al.
Published: (2023) -
Antipsychotic factors related to time to competency for forensic inpatients in a state psychiatric facility
by: Amber Lemons, PharmD, BCPP, et al.
Published: (2022) -
Perceptions and barriers of adverse drug reaction reporting within inpatient state psychiatric facilities
by: Carolyn O'Donnell, PharmD1, et al.
Published: (2023) -
Addition of a clinical pharmacist practitioner to an inpatient addiction triage team and related medication outcomes
by: Kim Ehrhard, PharmD, BCPP, et al.
Published: (2023) -
Positioning psychiatric pharmacists to improve mental health care
by: Julie A. Dopheide, PharmD, BCPP, FASHP, et al.
Published: (2022)